deepbio

News

Deep Bio becomes first Korean cancer diagnostic AI company to win CES Innovation Award

SEOUL, SOUTH KOREA, NOVEMBER 21, 2023 / PRNewswire/ - Won the CES Innovation Award for pioneering a new milestone in Korean cancer diagnosis AI soluti…

NOVEMBER 21, 2023

News

Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and Prognosis with AI Expertise

SEOUL, SOUTH KOREA, NOVEMBER 7, 2023 / PRNewswire/ - Deep Bio, a leading AI healthcare company specializing in deep learning and cancer pathology, is …

NOVEMBER 7, 2023

News

Deep Bio Earns Coveted Spot in Korea AI Startup 100 List for the Third Consecutive Year

Link to the Article SEOUL, South Korea, Oct. 4, 2023 /PRNewswire/ -- Deep Bio, a leader in artificial intelligence (AI)-powered cancer diagnostics, an…

OCTOBER 4, 2023

News

Deep Bio Announces Market Authorization from Swissmedic for DeepDx® Prostate, Paving the Way for Eur…

Swissmedic Clears Deep Bio's AI Prostate Cancer Diagnostic Software, Expanding Access to Advanced Healthcare in Europe                                …

SEPTEMBER 19, 2023

Publications

[Abstract] ASCO 2023 - Deep learning-based histomorphological pattern profiles for effective risk s…

Authors:JaeHeon Lee, Tae-Yeong Kwak, Joonyoung Cho, Sun Woo Kim, Hyeyoon ChangOrganizationsDeep Bio Inc., Seoul, South Korea BackgroundProstate cancer…

MAY 2023

Publications

[Abstract] ASCO 2023 - Validation of AI-based postoperative nomograms for biochemical recurrence in…

Authors:JaeHeon Lee, Tae-Yeong Kwak, Joonyoung Cho, Sun Woo Kim, Hyeyoon Chang, Hong Koo Ha OrganizationsDeep Bio Inc., Seoul, South Korea, Pusan Nati…

MAY 2023

Publications

[Abstract] ASCO 2023 - Exploring the efficacy of a continuous form of the histologic grade in prost…

Authors:Tae-Yeong Kwak, JaeHeon Lee, Joonyoung Cho, Sun Woo Kim, Hyeyoon Chang OrganizationsDeep Bio Inc., Seoul, South Korea BackgroundAdenocarcinoma…

MAY 2023

Publications

[Abstract] ASCO 2023 - Algorithm-based histologic grade and tumor ratio for radical prostatectomy: …

Authors:Tae-Yeong Kwak, JaeHeon Lee, Joonyoung Cho, Sun Woo Kim, Hyeyoon Chang, Hong Koo HaOrganizationsDeep Bio Inc., Seoul, South Korea, Pusan Natio…

MAY 2023

Publications

[Posters] AACR 2023 - Protein Receptor Prediction Model Using Only H&E Stained Images in Breast Can…

 

APRIL 2023

Publications

[Posters] AACR 2023 - Clonal Evaluation of ERG/SPINK1 Status to Determine Disease Progression Using…

 

APRIL 2023

Publications

[Posters] USCAP 2023 - Comparative Analysis of c-MET Expression Using Image Analysis Model in IHC S…

 

MARCH 2023

Publications

[Posters] USCAP 2023 - Evaluation of Attention-based Tumor Area Segmentation Deep Learning Models f…

MARCH 2023

News

Deep Bio Welcomes Grant Carlson as Chief Commercial Officer

Seasoned Industry Expert Joins Deep Bio to Drive Commercial Growth and Expansion. Deep Bio appoints Grant Carlson as the company’s Chief Commercial Of…

JULY 30, 2023

News

Deep Bio Secures Spot in South Korean Government's Prestigious "Super Gap Startup 1000+" Program

An award ceremony was held on July 4th, where Director Byeonggweon Lee from the Korean Ministry of SMEs and Startups (MSS) presented a plaque and expr…

JULY 07, 2023

Publications

[ARTICLE] Modern Pathology - Artificial intelligence system shows performance at the level of uropat…

MODERN PATHOLOGYARTICLE | VOLUME 35, ISSUE 10, P1449-1457, OCTOBER 2022Authors: Minsun Jung, Min-Sun Jin, Chungyeul Kim, Cheol Lee, Ilias P. Nikas, Je…

October 2022

News

Deep Bio’s AI Algorithm Helps Risk Stratification for Prostate Cancer

Collaborative research by Deep Bio and Dr. Lotan research team at Johns Hopkins Medicine was revealed at AUA 2023                                    S…

MAY 11, 2023

News

Deep Bio’s Novel Study Results Reaffirm Its Global Presence

USCAP 2023 is Deep Bio’s sixth consecutive year of presenting research abstracts                                    SEOUL, SOUTH KOREA (PRWEB) MARCH 1…

MARCH 14, 2023

News

Deep Bio and Visiopharm Announce a Collaborative Integration of a Clinical-Grade AI Prostate Cancer …

Pathologists can now have access to the state-of-the-art AI prostate cancer grading solution                                      SEOUL, SOUTH KOREA (…

November 15, 2022

News

Deep Bio Inc. successfully integrates DeepDx® Prostate algorithm into the HALO AP® platform from Ind…

Discover how Deep Bio Inc. (딥바이오) successfully integrates their DeepDx® Prostate algorithm into the HALO AP® platform from Indica Labs. Read the excit…

October 31, 2022

News

Deep Bio Acquires ISO 27001 Certification for an Information Security Management System

Enhanced security and reliability through adherence to globally recognized information security standards                                      SEOUL, …

October 27, 2022

News

Deep Bio Selected as ‘Korea AI Startup 100’ for Two Consecutive Years

AI experts expect Deep Bio to succeed in the healthcare industry with its innovative technology                                      SEOUL, SOUTH KORE…

October 21, 2022

News

Deep Bio Welcomes New Advisors to Accelerate Its Growth in Global Market

The new advisors will focus on Deep Bio’s overseas business expansion as well as strengthening its expertise in cancer pathology.                     …

October 11, 2022

News

Deep Bio’s AI Support for Prostate Cancer Diagnosis will be Deployed at Five Korean Hospitals

DeepDx®-Prostate Pro, designated as an Innovative Product by the Korea Public Procurement Service, is expected to improve pathology workflows in real …

October 10, 2022

News

Deep Bio Acquires MDSAP Certification, Paving the Way for Global Expansion

Demonstrated globally-recognized standards in safety and quality management as a medical software manufacturer.         SEOUL, SOUTH KOREA (PRWEB) AUG…

August 16, 2022

News

Deep Bio’s AI Support for Cancer Diagnosis has been Designated as an Innovative Product by the Korea…

This designation marks the Korean government’s recognition of innovation for DeepDx®-Prostate Pro.     SEOUL, SOUTH KOREA (PRWEB) JULY 25, 2022 - Deep…

July 25, 2022

Publications

[Posters] AACR 2022 - Breast Cancer Survival Analysis with the Size of the Infiltrative Cancer Area

 

April 2022

Publications

[Posters] AACR 2022 - Automated Gleason Grading of Digitized Frozen Section Prostate Tissue Slide Im…

 

April 2022

Publications

[Posters] AACR 2022 - A Deep Learning based Pancreatic Adenocarcinoma Survival Prediction Model Appl…

 

April 2022

Publications

[Posters] AACR 2022 - Recurrence Risk Prediction Based on Automatic Histologic Analysis of Breast Ca…

　 

April 2022

Publications

[Posters] AACR 2022 - Molecular Mapping of Prostate Cancer on Whole Mount Prostatectomy Specimens Us…

　 

April 2022

Publications

[Posters] USCAP 2022 - Ki-67 Index Regression Using Fully Convolutional Regression Network and Cance…

　

March 2022

Publications

[Posters] USCAP 2022 - Considering Uncertainty Improves Deep Learning-based Lung Cancer Subtyping

　

March 2022

Publications

[Posters] USCAP 2022 - Breast Cancer Survival Analysis through the Extracted Feature from the Prosta…

　

March 2022

Publications

[Posters] USCAP 2022 - Automatic Histological Grading of Breast Cancer Resection Tissue

　

March 2022

Publications

[Posters] USCAP 2022 - Deep Learning-based Automated Detection of Prostate Cancer Lesions

　 

March 2022

News

Deep Bio’s AI-based Cancer Diagnostic Software Demonstrated Uropathologist-level Performance

Independent external validation study results of Deep Bio’s AI algorithm for prostate cancer diagnosis were published in the Modern PathologySEOUL, SO…

May 13, 2022

News

Deep Bio Presents Research Results of AI-based Cancer Diagnosis and Prognosis at the AACR Annual Mee…

Five abstracts in prostate and breast cancers, Deep Bio’s main research areas, are presented during the online sessions. SEOUL, SOUTH KOREA (PRWEB) AP…

April 11, 2022

News

Join Deep Bio at AACR 2022!

Join Deep Bio at AACR 2022! At this year’s AACR, Deep Bio will present both on-site and virtually!Visit us at booth #1461 to share your thoughts on th…

April 1, 2022

News

Deep Bio Presented Deep Learning-based Cancer Research at the USCAP 111th Annual Meeting

Five researches in regards to deep learning-based cancer diagnosis and prognosis highlightedSEOUL, SOUTH KOREA (PRWEB) MARCH 23, 2022 - Deep Bio, a pi…

March 23, 2022

News

Deep Dive into High-Level Diagnostics

AI-mediated analysis of prostate biopsies enables faster and better diagnosesHealthcare systems are struggling with a pathologist shortfall. In the US…

October 21, 2021

News

[Interview] [Innovative Startups] Deep Bio to revolutionize prostate cancer diagnosis with AI platfo…

Korea has emerged as a "technology powerhouse" as the nation is seeing new innovative startups that are working on visualizing the once futuristic tec…

September 04, 2021

News

Embracing Pathology’s Digital Revolution with Deep Bio

Deep Bio stands at the front and center of digital transformation with DeepDx® ProstateDigital pathology is on the rise – and, with it, artificial int…

March 22, 2021

Blog post

#1. Designer들은 무엇을 보고 느꼈나? Designers Field Trip.

Interview#1. Designer들은 무엇을 보고 느꼈나? Designers Field Trip.길었던 2021년의 끝자락에 도착했습니다.크리스마스부터 새해까지 겨울방학에 돌입하는 Deep Bio는 우리의 지나온 길을 돌아보고 한 해의 마무리를 준비하고 있습니다.…

Dec 21, 2021

Videos

[Interview] Deep Bio CEO Interview - SBS Biz

March 30, 2022

News

Join Deep Bio at USCAP 2022

 Join Deep Bio at USCAP 2022We are excited to finally meet you in person at USCAP 2022!Explore how Deep Bio’s AI solutions have shaped digital patholo…

March 15, 2022

News

Deep Bio Announces Research Collaboration with a Major Cancer Institute

Deep Bio renews Research Collaboration Agreement with Dana-Farber Cancer Institute SEOUL, South Korea, July 22, 2021 - Deep Bio, a leading company in …

July 22, 2021

News

Deep Bio Collaborates with ARUP in AI Clinical Implementation Research

ARUP applies Deep Bio’s deep learning-based prostate cancer detection and classification solution for research SEOUL, SOUTH KOREA (PRWEB) JULY 16, 202…

July 16, 2021

News

Deep Bio Renews Software License Agreement with Stanford Medicine

Deep Bio provides its AI-based prostate cancer detection software for research SEOUL, SOUTH KOREA (PRWEB) JULY 16, 2021 - Deep Bio, a leading company …

July 16, 2021

News

Gestalt Diagnostics and Deep Bio Announce Strategic Relationship to Deliver Image Analysis Algorithm…

Spokane, WA, and Seoul, Korea (July 14, 2021) – Gestalt Diagnostics and Deep Bio today announced their strategic relationship on the development of an…

July 14, 2021

News

Deep Bio Presents its Novel Deep Learning-based Gleason Grading System in npj Digital Medicine

Deep Bio developed a novel deep learning-based prostate cancer detection model that demonstrates superb performance trained by a weakly supervised lea…

July 1, 2021

News

Deep Bio, Clinical Trial for ‘AI-powered Prostate Cancer Diagnosis’ in Korea

Seoul, South Korea- Deep Bio announced today that it had officially commenced clinical trial on ‘DeepDx-Prostate,’ a prostate biopsy AI-based diagnost…

April 11, 2019

News

Deep Bio Inc. ranks 1st in the CAMELYON17 Grand Challenge from post submitting in early February 201…

The Deep Bio research team set the record in the Camelyon Challenge 17’ currently positioning them in first place. The Camelyon17 Grand Challenge is a…

February 12, 2019

News

Deep Bio launches AI-diagnostic software on prostate cancer .."grants certifications"

Deep Bio announced today that it had released its artificial intelligence (AI) diagnostic products for the first time in the domestic press. The compa…

December 13, 2018

News

Deep Bio recieves ISO 13485

Deep Bio, an AI-powered medical service startup company, today announced that it had granted ISO 13485:2016 certification for its Quality Management S…

September 17, 2018

News

AI-driven diagnositc company, Deep Bio Inc. closes $5 Million USD in Series A

On May 28th, AI startup ‘Deep Bio’ succeeded in Series A funding from various venture capital companies in Korea. Deep Bio is a medicalAI company that…

March 2, 2018

News

Deep Bio Inc., takes on a challenge to develop software using AI

“Learning amount ↑ · Error ↓” Utilization as a clinical supporting device .. Artificial Intelligence (AI) has now made its headway into the biotech in…

September 18, 2017

News

DeepBio, 'prostate cancer' detection using AI ..closes seed rounding

Deep Bio, is a start-up company that develops artificial intelligence (AI) to diagnose prostate cancer. There are diagnostic imagining methods such as…

August 13, 2017